SCHEMBL30793901

SCHEMBL30793901

CCNC(=O)c1nn2c(c1Cl)CN(C(=O)OC(C)(C)C)CCC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ GPR119 Q8TDV5 2/20 0.37
▸ PDE4A P27815 2/20 0.36
▸ PDE4B Q07343 2/20 0.36
▸ PDE4C Q08493 2/20 0.36
▸ CYBB P04839 1/20 0.35
▸ NOX5 Q96PH1 1/20 0.35
▸ NOX4 Q9NPH5 1/20 0.35
▸ NOX1 Q9Y5S8 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ PDE4D Q08499 1/20 0.35
▸ NR1H2 P55055 1/20 0.35
▸ HTT P42858 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ PIK3CD O00329 1/20 0.34
▸ ESR2 Q92731 1/20 0.34
▸ NAMPT P43490 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30793502 0.88 GPR119 (0.38) MEN1KMT2AGPR119PDE4APDE4B
SCHEMBL30793120 0.87 GPR119 (0.37) MEN1KMT2AGPR119PDE4APDE4B
SCHEMBL30793124 0.87 MEN1 (0.40) MEN1KMT2APDE4APDE4BPDE4C
SCHEMBL30793957 0.85 MEN1 (0.37) MEN1KMT2APDE4APDE4BPDE4C
SCHEMBL25337280 0.84 NR1H2 (0.42) MEN1KMT2ACYBBNOX5NOX4
SCHEMBL26686738 0.84 MEN1 (0.43) MEN1KMT2AGPR119CYBBNOX5
SCHEMBL25335687 0.84 MEN1 (0.43) MEN1KMT2ACYBBNOX5NOX4
SCHEMBL26687047 0.84 ADORA1 (0.42) MEN1KMT2AGPR119CYBBNOX5
SCHEMBL24535149 0.81 MEN1 (0.40) MEN1KMT2AGPR119CYBBNOX5
SCHEMBL26686561 0.81 HPGD (0.41) MEN1KMT2ACYBBNOX5NOX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4540254-A1 TETRAHYDROPYRIDOPYRIMIDINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2025-04-23 — — EP disclosed
WO-2023244604-A1 TETRAHYDROPYRIDOPYRIMIDINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2023-12-21 — — WO disclosed
Send feedback